Orakl Oncology
French tech company | Builders Republic
About
Biotech platform that predicts how cancer patients will respond to drugs using tumor organoids grown from their own tissue — combining these living patient avatars with image analysis to help pharma teams design trials, stratify patients, find biomarkers and identify new targets. Spun out of Gustave Roussy.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2023
- City
- VILLEJUIF
- Region
- IDF
- Tracked rounds
- 2
- Amount raised
- 14 M€ raised since 2020
Funding rounds
- Seed — 2024
- Seed — 2023